← Evidence map

ArticleCancer letters2021

Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC).

Yihe Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

58 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33689775